[1]李铜强,刘家成,周 晨,等.提高经颈静脉肝内门体分流术治疗门静脉闭塞技术成功率的辅助靶标手段[J].介入放射学杂志,2022,31(08):805-809.
　LI Tongqiang,LIU Jiacheng,ZHOU Chen,et al.The auxiliary target means used for improving the success rate of TIPS in treating portal vein occlusion[J].journal interventional radiology,2022,31(08):805-809.
点击复制

提高经颈静脉肝内门体分流术治疗门静脉闭塞技术成功率的辅助靶标手段()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
31
期数:
2022年08
页码:
805-809
栏目:
临床研究
出版日期:
2022-09-30

文章信息/Info

Title:
The auxiliary target means used for improving the success rate of TIPS in treating portal vein occlusion
作者:
李铜强;  刘家成;  周 晨;  石 钦;  王迎亮;  黄松江;  杨崇图;  陈 杨;  熊 斌
Author(s):
LI Tongqiang;  LIU Jiacheng;  ZHOU Chen;  SHI Qin;  WANG Yingliang;  HUANG Songjiang;  YANG Chongtu;  CHEN Yang;  XIONG Bin.
Department of Radiology， Affiliated Union Hospital， Tongji Medical College， Huazhong University of Science and Technology， Hubei Province Key Laboratory of Molecular Imaging， Wuhan， Hubei Province 430022， China
关键词:
【关键词】 经颈静脉肝内门体分流术; 门静脉闭塞; 辅助靶标手段
文献标志码:
A
摘要:
【摘要】 目的 探讨提高经颈静脉肝内门体分流术（TIPS）治疗门静脉闭塞（PVO）技术成功率的辅助靶标手段及其安全性和有效性。 方法 纳入22例应用辅助靶标手段行TIPS治疗的PVO患者。其中11例应用经皮经肝门静脉靶标（PTPVT）技术，10例应用肝动脉导丝靶标（HAT）技术，1例两种辅助手段联合应用。 结果 1例失败，技术成功率为95.5%（21/22）。成功建立分流道患者门静脉压力梯度（PPG）由（28.4±7.7） mmHg（1 mmHg=0.133 kPa）降至（12.1±4.5） mmHg（P＜0.01）。术中未出现危及生命的严重并发症。中位随访时间14.9个月，术后累积支架通畅率为81.8%（18/22）；6例发生静脉曲张再出血，累积再出血率为27.3%；3例出现肝性脑病；1例因发生感染死亡。结论 TIPS是治疗PVO的安全有效方法，辅助靶标手段可提高TIPS的技术成功率。

参考文献/References:

［1］ Wang L， He F， Yue Z， et al. Techniques and long- term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis- related thrombotic total occlusion of main portal vein［J］. Sci Rep， 2017， 7： 10868.
［2］ Ponziani FR， Zocco MA， Campanale C， et al. Portal vein thrombosis： insight into physiopathology， diagnosis， and treatment［J］. World J Gastroenterol， 2010， 16： 143- 155.
［3］ Luca A， Miraglia R， Caruso S，et al. Short- and long- term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis［J］. Gut， 2011， 60： 846- 852.
［4］ Perarnau JM， Baju A， D’alteroche L， et al. Feasibility and long- term evolution of TIPS in cirrhotic patients with portal thrombosis［J］. Eur J Gastroenterol Hepatol， 2010， 22： 1093- 1098.
［5］ Liu J， Zhou B， Chen D， et al. Transjugular intrahepatic portosystemic shunt placement in patients with schistosomiasis- induced liver fibrosis［J］. Cardiovasc Intervent Radiol， 2019， 42： 1760- 1770.
［6］ Wang P， Qi X， Xu K. Evolution， progress， and prospects of research on transjugular intrahepatic portosystemic shunt applications［J］. J Interv Med， 2021， 4： 57- 61.
［7］ Han G， Qi X， He C， et al. Transjugular intrahepatic portosys- temic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis［J］. J Hepatol， 2011， 54： 78- 88.
［8］ Liu J， Zhou C， Shi Q， et al. Exploration of interventional therapy strategy for portal vein occlusion： a case series study［J］. Eur J Gastroenterol Hepatol， 2020， 32： 507- 516.
［9］ European Association for the Study of the Liver. EASL clinical practice guidelines： vascular diseases of the liver［J］. J Hepatol， 2016， 64： 179- 202.
［10］ Chen Y， Ye P， Li Y， et al. Percutaneous transhepatic balloon- assisted transjugular intrahepatic portosystemic shunt for chronic， totally occluded， portal vein thrombosis with symptomatic portal hypertension：procedure technique，safety，and clinical applications［J］. Eur Radiol， 2015， 25： 3431- 3437.
［11］ Liu J， Meng J， Zhou C， et al. A new choice of stent for transjugular intrahepatic portosystemic shunt creation： viabahn ePTFE covered stent/bare metal stent combination［J］. J Intervent Med， 2021， 4： 32- 38.
［12］ Senzolo M， Tibbals J， Cholongitas E， et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation［J］. Aliment Pharmacol Ther， 2006， 23： 767- 775.
［13］ Luo J， Li M， Zhang Y， et al. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy［J］. Eur Radiol， 2018， 28： 3661- 3668.
［14］ de Franchis R， Baveno Ⅵ Faculty. Expanding consensus in portal hypertension： report of the Baveno Ⅵ consensus workshop： stratifying risk and individualizing care for portal hypertension［J］. J Hepatol， 2015， 63： 743- 752.
［15］ Li M， Luo J， Chen J， et al. Application of percutaneous transluminal sharp recanalization in transjugular intrahepatic portosystemic shunt for patients with chronic portal vein occlusion［J］. Diagn Interv Radiol， 2021， 27： 257- 262.
［16］ Boyer TD， Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension［J］. Hepatology， 2005， 41： 386- 400.
［17］ Krajina A， Hulek P， Fejfar T， et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunt（TIPS）［J］. Cardiovasc Intervent Radiol， 2012， 35： 1295- 1300.
［18］ 陆 孜，潘文秋，赵 卫，等． 经颈静脉肝内门体分流术联合部分脾动脉栓塞术对肝硬化脾功能亢进患者肝功能和外周血细胞的中远期影响［J］． 介入放射学杂志， 2021， 30：163- 167．
［19］ Leong S， Kok HK， Govender P， et al. Reducing risk of transjugular intrahepatic portosystemic shunt using ultrasound guided single needle pass［J］. World J Gastroenterol， 2013， 19： 3528- 3530.
［20］ 汤善宏，秦建平，束庆飞，等． TIPS 术中引导门静脉分支穿刺方法［J］． 介入放射学杂志， 2014， 23：640- 643．
［21］ Buechter M， Kahraman A， Manka P， et al. Partial spleen embolization reduces the risk of portal hypertension- induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation［J］. PLoS One， 2017， 12： e0177401.

相似文献/References:

[1]唐世伟,赵新建,王忠敏,等.TIPS对比EBL治疗肝硬化食管静脉曲张出血Meta分析[J].介入放射学杂志,2016,(09):761.
　TANG Shi- wei,ZHAO Xin- jian,WANG Zhong- min,et al.The treatment of cirrhosis esophageal variceal bleeding： a meta- analysis of TIPS versus EBL[J].journal interventional radiology,2016,(08):761.
[2]彭伦华,王运兵,郭 灿.球囊阻断逆行经静脉闭塞对比经颈静脉肝内门体分流治疗门脉高压胃底静脉曲张出血的Meta分析[J].介入放射学杂志,2016,(10):843.
　PENG Lun- hua,WANG Yun- bing,GUO Can.Balloon- occluded retrograde transvenous obliteration versus TIPS for treatment of gastric fundus varices due to portal hypertension： a meta- analysis[J].journal interventional radiology,2016,(08):843.
[3]苗同国,褚建国,黄 鹤,等.经颈静脉肝内门静脉左支门体分流中支架位置对远期疗效的影响 [J].介入放射学杂志,2017,(04):299.
　MIAO Tongguo,CHU Jianguo,HUANG He,et al.The influence of the stent position in transjugular intrahepatic left branch of portal vein portosystemic shunt on the long- term effect[J].journal interventional radiology,2017,(08):299.
[4]韩 强,李迎春,李松蔚,等.经颈静脉肝内门体分流双支架技术研究进展 [J].介入放射学杂志,2017,(09):859.
　HAN Qiang,LI Yingchun,LI Songwei,et al.Dual stent technology used for TIPS： recent progress in research[J].journal interventional radiology,2017,(08):859.
[5]胡晓钢,金红来,鲁 军,等.经颈静脉肝内门体分流术治疗门静脉血栓形成伴急性消化道大出血效果评价[J].介入放射学杂志,2018,27(06):516.
　HU Xiaogang,JIN Honglai,LU Jun,et al.TIPS for the treatment of portal vein thrombosis associated with acute massive hemorrhage of gastrointestinal tract： evaluation of clinical effect[J].journal interventional radiology,2018,27(08):516.
[6]马鹍鹏,梁松年,钟红珊,等.Viatorr支架行TIPS术治疗门静脉高压性静脉曲张消化道出血效果评估[J].介入放射学杂志,2020,29(04):380.
　MA Kunpeng,LIANG Songnian,ZHONG Hongshan,et al.TIPS creation by using Viatorr stent-graft for the treatment of variceal gastrointestinal bleeding due to portal hypertension: evaluation of its clinical efficacy[J].journal interventional radiology,2020,29(08):380.
[7]邓黎严琰,陈 勇,叶 鹏,等.经颈静脉肝内门体分流术初步分析门静脉系统肝脏相关血液成分[J].介入放射学杂志,2020,29(06):608.
　DENG Liyanyan,CHEN Yong,YE Peng,et al.Preliminary analysis of liver- related blood components in portal vein system via TIPS approach[J].journal interventional radiology,2020,29(08):608.
[8]于 翔,谢 坪,成思航,等.经颈静脉肝内门体分流术前外周血炎症指标对术后肝性脑病的预测价值 [J].介入放射学杂志,2021,30(09):937.
　YU Xiang,XIE Ping,CHENG Sihang,et al.The clinical value of preoperative peripheral blood inflammatory markers in predicting the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J].journal interventional radiology,2021,30(08):937.
[9]曾 娇,郭贵海.经颈静脉肝内门体分流术支架选择和释放位置研究进展[J].介入放射学杂志,2021,30(09):964.
　ZENG Jiao,GUO Guihai..Research progress in the selection of the stent and its release site in TIPS therapy[J].journal interventional radiology,2021,30(08):964.
[10]高西杰,赵剑波,谭 卿,等.Viatorr支架经颈静脉肝内门体分流术后显性肝性脑病发生率及其危险因素分析[J].介入放射学杂志,2021,30(10):998.
　GAO Xijie,ZHAO Jianbo,TAN Qing,et al.Overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with Viatorr stent： analysis of its incidence and risk factors[J].journal interventional radiology,2021,30(08):998.

备注/Memo

备注/Memo:
（收稿日期：2021- 07- 14）
（本文编辑：边 佶）
更新日期/Last Update: 2022-09-27